Analysis
Posts are repackaging neomycin, a manufacturing residue in some vaccines, as evidence that vaccination causes hearing loss and tinnitus. The earliest captured example of the ingredient-to-hearing-loss claim was indexed on 30 September 2026: Americaonly9, P046120 quoted a vaccine-toxicity list that linked neomycin to hearing loss. A more prominent ValerieAnne1970 post, P053483, indexed on 6 October, developed the claim into a stand-alone warning, listed injectable polio vaccine among the products concerned, invoked a drug boxed warning and urged readers to refuse injections. These are related stages of the same ingredient narrative, rather than evidence that it began on 6 October. The expanded matched set contains 116 URL-distinct records, including quoted material and at least one rebuttal, with 5,092 exported engagements; 4,653, or 91.4%, belong to the 6 October record. Most matches are from X, with one online-news record. Japanese, Chinese and German examples show translated reuse, including P053858 and P057653; their language does not establish audience location. Country fields combine the export’s author, source and article metadata with explicit content mentions and should not be read as a map of proven uptake effects. The medical framing merges different exposures: the IPOL label, Description, printed page 2, describes less than 5 nanograms of residual neomycin per dose, whereas the oral neomycin label warns about toxicity during therapeutic use. That warning does not demonstrate the claimed hearing injury from trace vaccine residues. The reviewed 135-item Polio Pulse archive already contains ingredient-toxicity and historical-contamination narratives, especially A028 and A018; the hearing outcome and borrowed drug warning are a material evolution within that established frame. The refusal language creates a plausible vaccination-confidence concern, but the captured engagement is concentrated and no missed vaccination, clinical injury, coordinated campaign or accelerating diffusion is established. Original posts could not be retrieved live, so circulation and counter values remain observations from the supplied exports.
Recommendations
Use the UNICEF DCE listening-and-contextualization approach to prepare a brief, product-specific explanation for health workers and community managers where the concern appears. Begin with the caregiver’s question, explain the difference between a therapeutic antibiotic dose and trace manufacturing residues, and link to the relevant vaccine label while acknowledging genuine allergy precautions. Following the Polio Message Guide, favour educational content and trusted clinical messengers over a broad campaign repeating the allegation. Do not endorse detox remedies. Reassess the medium rating if independent local circulation, delayed appointments or documented refusal appears; route individual health concerns to clinical assessment and adverse-event reporting.